My hypothesis: Dec 4th CTAD and repeated Monday in the presentation.
AVXL has been under heavy tute accumulation since Dec 4th and accelerated after the 1st of the year. The doubling of volume gives weight to this theory. Look at volume since Dec 4 and look at CMF (money flowing into the stock)Since Jan 3rd.
jimmy667 Wednesday, 02/05/20 05:07:25 PM
Re: 123tom post# 234157 0
Post #
234168
of 235874
Volume thesis -Back-tested.
Volume is likely from a shift in investor sentiment since CTAD Dec 4th presentation.
This is likely a follow-through from CTAD. AVXL made a big jump after the Anavex CTAD presentation. On Dec 3rd the stock was $2.36 and made a big jump to the $3.40s on a super-large volume before trading back down but volume remained higher than before Dec 4th and persists to this day.
Besides volume pay close attention to the CMF which indicated money flowing into the stock that went positive on Jan 3rd and has stayed green. Now compare the volume bars of the last three days to the volume bars of Dec 4 and 5 and all the volume bars between to those of before Dec 4th,2019. Ladies and Gentlemen what you are seeing is the persistent accumulation of AVXL since CTAD Dec 4th, 2019. The last three days are a continuation of that and there is no reason to assume it will not continue. Trade this ticker and your peril if you are long as IMO this will not be backing up much for fundamental reasons and no one can predict what the market makers will do with their "Formula 409." But it is designed to clean money from your account when you trade against them. I believe the time has come that the buy and hold strategy will be superior as it usually is in the long run. (Assuming proper DD)
Here is what I wrote on Jan 16th when the stock finished at $3.17:
jimmy667 Thursday, 01/16/20 09:23:41 PM
Re: 123tom post# 230769 0
Post #
230774
of 234162
A tale of two stocks. The switch was flipped on the trading volume on Dec 4th. Take a look at the volume bars on the 3-month daily chart. The one here on Ihub mobile app works great for this examination, make sure volume is turned on. Average daily has about doubled starting with the CTAD on Dec 4th. Whoever says the "Market" was not impressed with this year's presentation at CTAD is not examining the evidence. Ladies and Gentlemen Anavex Life Science stock looks like it is currently in a heavy accumulation phase.